CAGAS
IRWD icon

Capital Advisory Group Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-143
Closed -$2K – 322
2021
Q3 		$2K Buy
+143
New +$1.85K ﹤0.01% 502

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Capital Advisory Group Advisory Services's IRWD Position: Q4 2021 in Review

Capital Advisory Group Advisory Services sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 143 shares — an estimated $2K sold.

Capital Advisory Group Advisory Services first reported a position in IRWD in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Capital Advisory Group Advisory Services reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 143 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $2K.
  • Capital Advisory Group Advisory Services first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Capital Advisory Group Advisory Services's Ironwood Pharmaceuticals position peaked at $2K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2021, filed 15 Feb 2022.